What's Going On With Synopsys Shares Thursday?

Synopsys guided FY2027 adjusted EPS to $19.04-$19.12 versus $17.32 consensus and revenue to $11.10-$11.20B versus $10.73B expected. The company also set a FY2026-30 framework targeting roughly 15% annual revenue growth, a ~50% FY2030 operating margin and mid-20% free-cash-flow growth, alongside a planned $1B share repurchase. Strategic AI partnerships include a multi-year OpenAI collaboration on a chip-design model and an Amazon agreement worth more than $1B for silicon IP and AI-powered engineering software; shares rose 3.46% to $450.

Analysis

The investable change is not the near-term beat but the implied durability of Synopsys’ pricing power: a mix shift toward recurring software, IP royalties and AI-enabled workflow seats can raise lifetime value while reducing the historical lumpiness of large design wins. If execution holds, the market should increasingly value SNPS on free-cash-flow compounding rather than its legacy EDA multiple, supporting a rerating relative to CDNS over the next 6-18 months. The buyback is marginal to valuation but provides a near-term technical bid after the initial guidance-driven move.

Amazon’s commitment validates Synopsys as a strategic supplier to hyperscaler custom silicon programs, where incremental tape-outs can create high-margin royalty annuities. The less obvious beneficiary is AMZN: faster iteration and lower engineering bottlenecks improve the economics of internally designed accelerators and networking chips, potentially reducing dependence on merchant suppliers such as NVDA and AVGO over a multi-year horizon. That said, the direct earnings impact to AMZN is immaterial in the next 1-3 quarters; this is a capex-efficiency and supply-control option rather than a near-term profit driver.

Consensus may over-extrapolate the AI partnership into immediate revenue. Semiconductor design verification has long qualification cycles, and customers will require demonstrable gains in power, performance, area and first-pass silicon success before displacing established engineering workflows; meaningful monetization is more likely in FY28-FY30. The core risk is customer concentration and custom-chip spending cyclicality: a delay in hyperscaler silicon roadmaps, weaker IP royalty ramps, or operating-margin progression below the stated path would expose a premium-multiple de-rating quickly.

Key Decisions for Investors

• Accumulate SNPS on post-event consolidation rather than chase a single-digit gap; target a 6-12 month long with a 15-20% upside case from sustained bookings and margin conversion, versus 10-12% downside if the next earnings call shows weaker backlog conversion or IP royalty timing.
• Use a relative-value position: long SNPS / short CDNS in equal dollar amounts for 6-12 months. The thesis is that hyperscaler IP and AI workflow monetization broadens SNPS’ addressable pool faster; exit if CDNS demonstrates superior bookings growth for two consecutive quarters or SNPS’ margin trajectory slips.
• Do not add AMZN solely on this development. Instead, monitor AWS custom-silicon deployment metrics and capex efficiency through the next two quarterly reports; evidence that internally designed chips are displacing third-party accelerator purchases would strengthen a 12-24 month long AMZN versus semiconductor suppliers with concentrated hyperscaler exposure.
• Set a downside alert on SNPS around the next guidance update: reduce exposure if management cuts the medium-term growth or operating-margin framework, or if large-customer contract value fails to translate into deferred revenue/backlog growth. Those outcomes would distinguish headline partnerships from economically material adoption.